Impact of Plasma Aldosterone Levels for Prediction of In-Stent Restenosis
Open Access
- 20 January 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (6) , 785-788
- https://doi.org/10.1016/j.amjcard.2005.10.017
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapyAmerican Journal of Hypertension, 2003
- Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart FailureCirculation Research, 2003
- Aldosterone Inhibits Inducible Nitric Oxide Synthase in Neonatal Rat CardiomyocytesEndocrinology, 2003
- Aldosterone induces a vascular inflammatory phenotype in the rat heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2002
- Aldosterone Breakthrough During Angiotensin II Receptor Antagonist Therapy in Stroke-Prone Spontaneously Hypertensive RatsHypertension, 2002
- Pathophysiological effects of aldosterone in cardiovascular tissuesTrends in Endocrinology & Metabolism, 2001
- Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 βEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells.Journal of Biological Chemistry, 1994